1095207-05-8

1095207-05-8 structure
1095207-05-8 structure
  • Name: Crenezumab
  • Chemical Name: Crenezumab
  • CAS Number: 1095207-05-8
  • Molecular Formula:
  • Molecular Weight:
  • Catalog: Research Areas Neurological Disease
  • Create Date: 2023-04-29 17:14:34
  • Modify Date: 2025-08-21 15:46:24
  • Crenezumab (MABT 5102A; RG 7412) is a fully humanized anti-Aβ monoclonal antibody that binds multiple forms of Aβ, such as soluble, oligomeric and fibrillar, for use in Alzheimer's disease research[1].

Name Crenezumab
Description Crenezumab (MABT 5102A; RG 7412) is a fully humanized anti-Aβ monoclonal antibody that binds multiple forms of Aβ, such as soluble, oligomeric and fibrillar, for use in Alzheimer's disease research[1].
Related Catalog
References

[1]. S Zampar, et al. N-terminal heterogeneity of parenchymal and vascular amyloid-β deposits in Alzheimer's disease. Neuropathol Appl Neurobiol. 2020 Dec;46(7):673-685.  

No Any Chemical & Physical Properties
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.